AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Autopsy exposes adverse effects of vaccine.

Vaccine Weekly

| April 02, 2003 | COPYRIGHT 2003 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2003 APR 2 - (NewsRx.com & NewsRx.net) -- The only clinical trial for an experimental Alzheimer disease (AD) vaccine was halted last year when 15 of the trial participants developed severe brain inflammation. Now James Nicoll and colleagues have presented the first analysis of the vaccine's effects on the human brain.

In the U.S. alone, AD affects nearly 4 million people, and the number is expected to triple in the next 30 years. The brain of an AD patient is characterized by tangled bundles of nerve fibers and amyloid "plaques" - clusters of a sticky protein called amyloid-beta. In mice, a vaccine directed against the amyloid-beta peptide clears the plaques and alleviates the memory ...

Related articles from newspapers, magazines, journals, and more
Strong animal data for amyloid AD vacc.(Alzheimer's disease)(vaccines)(Brief...
Newspaper article from: Pharma Marketletter May 22, 2006 700+ words
...by Marcel Maier, developed a vaccine using a special type of amyloid...brain inflammation that a previous AD vaccines encountered in humans. Commenting...strategies for delaying or preventing AD, this new vaccine might be able to treat the disease...
AD vaccine fails to prevent neurodegeneration
Magazine article from: Inpharma Weekly Anonymous July 26, 2008 700+ words
...investigating the relationship between Alzheimer's disease (AD) vaccine [AN172, Elan Pharmaceutical] and Aβ^sub...study included 80 patients, randomly assigned to receive AD vaccine either 50g or 225g with an adjuvant (QS-21; n = 64...
Prima/Prana deal to find AD vaccine.
Newspaper article from: Pharma Marketletter August 18, 2003 700+ words
...250,000. Prima's new Panvax vaccine technology, DCtag, will be utilized...clinical evaluation for the treatment of AD (Marketletters passim). Under the...and royalties from a successful AD vaccine. No other details of the deal were...
Edible AD vaccine grown in GM rice.(alzheimer's disease)(Brief article)
Newspaper article from: Pharma Marketletter July 2, 2007 700+ words
...Japan are attempting to grow an edible vaccine against Alzheimer's disease. According...protein that aggregates in the brains of AD patients. One of the scientists involved...the researchers hope to test the edible vaccine in animals.
Novel Ad recombinant vaccine to HIV-1 developed.
Newspaper article from: AIDS Vaccine Week May 19, 2003 700+ words
...adenovirus recombinant vaccine to HIV-1. "Human...studied extensively as vaccine carrier for antigens...promising results as vaccines, the pre-existing...the efficacy of such vaccines in this target species...alternative adenoviral vaccine carrier based on a virus...
ANTI-ALZHEIMER'S VACCINE OFF AND RUNNING IN SEPARATE CENTERS, IMMUNIZATION...
Magazine article from: BIOWORLD Today Leff, David N. December 21, 2000 700+ words
...invade the body. Vaccines draw beads in their...So the idea of a vaccine against Alzheimer's disease (AD) seems somehow counter...memory loss in these AD surrogate animals...And Bolts Of Anti-AD Immunization Formulating the vaccine, Morgan explained...
Researchers Successfully Immunize Mice Against AD.(Alzheimer's disease vaccine...
Newspaper article from: Pain & Central Nervous System Week August 25, 2001 700+ words
...And, at the same time, the vaccine reduced the amount of soluble...We believe that our peptide vaccine isn't toxic to nerve cells...role of amyloid proteins in AD and other forms of dementia...early clinical trials of the new vaccine could begin within one year...
Participants Sought For Phase I Study of Experimental Ad 5 HIV-1 Vaccine.
Newspaper article from: AIDS Weekly May 21, 2001 700+ words
...immunogenicity of an experimental Ad5 HIV-1gag vaccine being developed by Merck & Co., Inc. The vaccine consists of a defective adenovirus serotype...Patients will receive either the study vaccine at a dose of 1x10(8), 1x10(9...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA